Chronic phenmetrazine treatment promotes D2 dopaminergic and α2-adrenergic receptor desensitization and alters phosphorylation of signaling proteins and local cerebral glucose metabolism in the rat brain
- 23 February 2021
- journal article
- research article
- Published by Elsevier BV in Brain Research
- Vol. 1761, 147387
- https://doi.org/10.1016/j.brainres.2021.147387
Abstract
No abstract availableKeywords
Funding Information
- Wake Forest University School of Medicine
This publication has 68 references indexed in Scilit:
- Activation of GABAB receptors inhibits protein kinase B /Glycogen Synthase Kinase 3 signalingMolecular Brain, 2012
- Extracellular Signal-Regulated Kinase Signaling in the Ventral Tegmental Area Mediates Cocaine-Induced Synaptic Plasticity and Rewarding EffectsJournal of Neuroscience, 2011
- Stimulant Abuse: Pharmacology, Cocaine, Methamphetamine, Treatment, Attempts at PharmacotherapyPrimary Care: Clinics in Office Practice, 2011
- GSK-3β activity and hyperdopamine-dependent behaviorsNeuroscience & Biobehavioral Reviews, 2011
- D1 and D2 dopamine receptors differentially mediate the activation of phosphoproteins in the striatum of amphetamine-sensitized ratsPsychopharmacology, 2010
- Cocaine-induced hyperactivity and sensitization are dependent on GSK3Neuropharmacology, 2009
- Selective Suppression of Cocaine- versus Food-Maintained Responding by Monoamine Releasers in Rhesus Monkeys: Benzylpiperazine, (+)Phenmetrazine, and 4-BenzylpiperidineThe Journal of pharmacology and experimental therapeutics, 2009
- Cocaine regulates protein kinase B and glycogen synthase kinase‐3 activity in selective regions of rat brainJournal of Neurochemistry, 2008
- Neuroplasticity in the mesolimbic dopamine system and cocaine addictionBritish Journal of Pharmacology, 2008
- Role of monoamine transporters in mediating psychostimulant effectsThe AAPS Journal, 2005